Scholarlink

Tavaborole is the first oxaborole antifungal agent that was approved on July 2014 by the FDA as a topical therapy for toe nail onychomycosis caused by Trichophyton rubrum and Trichophyton mentagrophytes [1]. It is marketed under the brand name ‘Kerydin’.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Tavaborole

  • 章节

  • 发表日期：

    2025年

查看全文
  • Aditya Kumar Bubna

摘要

Tavaborole is the first oxaborole antifungal agent that was approved on July 2014 by the FDA as a topical therapy for toe nail onychomycosis caused by Trichophyton rubrum and Trichophyton mentagrophytes [1]. It is marketed under the brand name ‘Kerydin’.